The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Research Report 2024
Synopsis
The global Inactivated Porcine Atrophic Rhinitis Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Inactivated Porcine Atrophic Rhinitis Vaccine in Sows is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Inactivated Porcine Atrophic Rhinitis Vaccine include Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology and Tianjin Ringpu Bio-Technology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Atrophic Rhinitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Atrophic Rhinitis Vaccine.
Report Scope
The Inactivated Porcine Atrophic Rhinitis Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inactivated Porcine Atrophic Rhinitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Porcine Atrophic Rhinitis Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
HIPRA
Bioveta
China Animal Husbandy Industry
Wuhan Keqian Biology
Pulike Bio-Engineering
Tiankang Animal Science Bio-Technology
Tianjin Ringpu Bio-Technology
Segment by Type
Tissue Culture Origin
Cell Line Origin
Segment by Application
Sows
Gilts
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Porcine Atrophic Rhinitis Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Inactivated Porcine Atrophic Rhinitis Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Inactivated Porcine Atrophic Rhinitis Vaccine in Sows is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Inactivated Porcine Atrophic Rhinitis Vaccine include Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology and Tianjin Ringpu Bio-Technology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Atrophic Rhinitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Atrophic Rhinitis Vaccine.
Report Scope
The Inactivated Porcine Atrophic Rhinitis Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inactivated Porcine Atrophic Rhinitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Porcine Atrophic Rhinitis Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
HIPRA
Bioveta
China Animal Husbandy Industry
Wuhan Keqian Biology
Pulike Bio-Engineering
Tiankang Animal Science Bio-Technology
Tianjin Ringpu Bio-Technology
Segment by Type
Tissue Culture Origin
Cell Line Origin
Segment by Application
Sows
Gilts
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Porcine Atrophic Rhinitis Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Market by Application
1.3.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Sows
1.3.3 Gilts
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Perspective (2019-2030)
2.2 Inactivated Porcine Atrophic Rhinitis Vaccine Growth Trends by Region
2.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Dynamics
2.3.1 Inactivated Porcine Atrophic Rhinitis Vaccine Industry Trends
2.3.2 Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers
2.3.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges
2.3.4 Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Revenue
3.1.1 Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Revenue (2019-2024)
3.1.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue
3.4 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio
3.4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2023
3.5 Inactivated Porcine Atrophic Rhinitis Vaccine Key Players Head office and Area Served
3.6 Key Players Inactivated Porcine Atrophic Rhinitis Vaccine Product Solution and Service
3.7 Date of Enter into Inactivated Porcine Atrophic Rhinitis Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Type
4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2025-2030)
5 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Application
5.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2019-2030)
6.2 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2019-2024)
6.4 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2019-2030)
7.2 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2019-2024)
7.4 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2019-2030)
9.2 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2019-2024)
9.4 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Detail
11.1.2 Merck Animal Health Business Overview
11.1.3 Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.1.4 Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
11.1.5 Merck Animal Health Recent Development
11.2 HIPRA
11.2.1 HIPRA Company Detail
11.2.2 HIPRA Business Overview
11.2.3 HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.2.4 HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
11.2.5 HIPRA Recent Development
11.3 Bioveta
11.3.1 Bioveta Company Detail
11.3.2 Bioveta Business Overview
11.3.3 Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.3.4 Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
11.3.5 Bioveta Recent Development
11.4 China Animal Husbandy Industry
11.4.1 China Animal Husbandy Industry Company Detail
11.4.2 China Animal Husbandy Industry Business Overview
11.4.3 China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.4.4 China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
11.4.5 China Animal Husbandy Industry Recent Development
11.5 Wuhan Keqian Biology
11.5.1 Wuhan Keqian Biology Company Detail
11.5.2 Wuhan Keqian Biology Business Overview
11.5.3 Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.5.4 Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
11.5.5 Wuhan Keqian Biology Recent Development
11.6 Pulike Bio-Engineering
11.6.1 Pulike Bio-Engineering Company Detail
11.6.2 Pulike Bio-Engineering Business Overview
11.6.3 Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.6.4 Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
11.6.5 Pulike Bio-Engineering Recent Development
11.7 Tiankang Animal Science Bio-Technology
11.7.1 Tiankang Animal Science Bio-Technology Company Detail
11.7.2 Tiankang Animal Science Bio-Technology Business Overview
11.7.3 Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.7.4 Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
11.7.5 Tiankang Animal Science Bio-Technology Recent Development
11.8 Tianjin Ringpu Bio-Technology
11.8.1 Tianjin Ringpu Bio-Technology Company Detail
11.8.2 Tianjin Ringpu Bio-Technology Business Overview
11.8.3 Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.8.4 Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
11.8.5 Tianjin Ringpu Bio-Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tissue Culture Origin
Table 3. Key Players of Cell Line Origin
Table 4. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2019-2024)
Table 8. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2025-2030)
Table 10. Inactivated Porcine Atrophic Rhinitis Vaccine Market Trends
Table 11. Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers
Table 12. Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges
Table 13. Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints
Table 14. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players (2019-2024)
Table 16. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2023)
Table 17. Ranking of Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Inactivated Porcine Atrophic Rhinitis Vaccine Product Solution and Service
Table 21. Date of Enter into Inactivated Porcine Atrophic Rhinitis Vaccine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2019-2024)
Table 25. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2025-2030)
Table 27. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Application (2019-2024)
Table 29. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Application (2025-2030)
Table 31. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 46. Merck Animal Health Company Detail
Table 47. Merck Animal Health Business Overview
Table 48. Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 49. Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024) & (US$ Million)
Table 50. Merck Animal Health Recent Development
Table 51. HIPRA Company Detail
Table 52. HIPRA Business Overview
Table 53. HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 54. HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024) & (US$ Million)
Table 55. HIPRA Recent Development
Table 56. Bioveta Company Detail
Table 57. Bioveta Business Overview
Table 58. Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 59. Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024) & (US$ Million)
Table 60. Bioveta Recent Development
Table 61. China Animal Husbandy Industry Company Detail
Table 62. China Animal Husbandy Industry Business Overview
Table 63. China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 64. China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024) & (US$ Million)
Table 65. China Animal Husbandy Industry Recent Development
Table 66. Wuhan Keqian Biology Company Detail
Table 67. Wuhan Keqian Biology Business Overview
Table 68. Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 69. Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024) & (US$ Million)
Table 70. Wuhan Keqian Biology Recent Development
Table 71. Pulike Bio-Engineering Company Detail
Table 72. Pulike Bio-Engineering Business Overview
Table 73. Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 74. Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024) & (US$ Million)
Table 75. Pulike Bio-Engineering Recent Development
Table 76. Tiankang Animal Science Bio-Technology Company Detail
Table 77. Tiankang Animal Science Bio-Technology Business Overview
Table 78. Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 79. Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024) & (US$ Million)
Table 80. Tiankang Animal Science Bio-Technology Recent Development
Table 81. Tianjin Ringpu Bio-Technology Company Detail
Table 82. Tianjin Ringpu Bio-Technology Business Overview
Table 83. Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 84. Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024) & (US$ Million)
Table 85. Tianjin Ringpu Bio-Technology Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type: 2023 VS 2030
Figure 3. Tissue Culture Origin Features
Figure 4. Cell Line Origin Features
Figure 5. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application: 2023 VS 2030
Figure 7. Sows Case Studies
Figure 8. Gilts Case Studies
Figure 9. Inactivated Porcine Atrophic Rhinitis Vaccine Report Years Considered
Figure 10. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region: 2023 VS 2030
Figure 13. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players in 2023
Figure 14. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2023
Figure 16. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2019-2030)
Figure 18. United States Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2019-2030)
Figure 22. Germany Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2019-2030)
Figure 30. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2019-2030)
Figure 38. Mexico Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2019-2030)
Figure 42. Turkey Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Merck Animal Health Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
Figure 45. HIPRA Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
Figure 46. Bioveta Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
Figure 47. China Animal Husbandy Industry Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
Figure 48. Wuhan Keqian Biology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
Figure 49. Pulike Bio-Engineering Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
Figure 50. Tiankang Animal Science Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
Figure 51. Tianjin Ringpu Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
